Key result
Elevated hs-CRP linked to ~26% greater odds of high depression symptom severity.
Why the study?
Systemic inflammation may play a role in depression, prompting an evaluation of the association between hs-CRP and depression symptom severity measured by the PHQ-9.
Does elevated hs-CRP associate with increased depression symptom severity in U.S. adults?
Cross-Sectional (n=15,525)
Yes
Does elevated hs-CRP associate with increased depression symptom severity in U.S. adults?
Odds Ratio: 1.26 (95% CI 1.04–1.51)
p-value: p=0.018
Elevated hs-CRP is independently associated with higher depression symptom severity, particularly in the somatic symptom domain, among U.S. adults.
Elevated hs-CRP may identify higher depression risk; leaves open causal role and screening utility.
Background Systemic inflammation may play a role in depression. This study examined the association between high-sensitivity C-reactive protein (hs-CRP), a well-established biomarker of systemic inflammation, and the severity of depression symptoms as measured by the Patient Health Questionnaire (PHQ-9). Methods Data from the National Health and Nutrition Examination Survey (NHANES) 2015-2023 were utilized. Depression was classified as low (PHQ-9 < 10) and high (PHQ-9 ≥ 10). hs-CRP levels were dichotomized into low (≤ 3 mg/L) and high (> 3mg/L). Logistic regression models were used to analyze the association between hs-CRP and depression symptom severity, adjusting for demographic, socioeconomic, health-related covariates, while considering the NHANES complex sampling design. Results Among 15,525 U.S. adults, elevated hs-CRP levels were significantly associated with high depression symptom severity. hs-CRP > 3mg/L was associated with 26% greater odds of high depression symptom severity (adjusted OR=1.26; 95% CI: 1.04-1.51; p-value=0.018). Other factors associated with greater odds of high depression symptom severity included female sex, younger age (20-39 years), low-income status, unmarried status, tobacco use, multimorbidity, and timing of survey responses in relation to the onset of the COVID-19 pandemic. Exploratory depression symptom-domain analysis showed that hs-CRP was significantly associated with somatic symptom-domain (p-value < 0.001) while not significantly associated with cognitive/affective symptom-domain (p-value=0.056). Conclusion Depression symptom severity is influenced by many demographic, socioeconomic, behavioral, and health-related factors. The study findings support an independent association between elevated hs-CRP and depression symptom severity, and the significance of the association could depend on the specific depression symptom-domain.
No takes yet. Share an insight, caveat, or question.
Arellano et al. (2026) conducted a cross-sectional in Depression (n=15,525). Elevated hs-CRP (> 3mg/L) vs. Low hs-CRP (≤ 3 mg/L) was evaluated on High depression symptom severity (PHQ-9 ≥ 10) (OR 1.26, 95% CI 1.04-1.51, p=0.018). Elevated hs-CRP (> 3mg/L) was significantly associated with greater odds of high depression symptom severity among U.S. adults (adjusted OR 1.26; 95% CI 1.04-1.51; p=0.018).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: